Increased plasma cholesteryl ester transfer activity in obese children

Atherosclerosis

Volumn 129, Issue 1, 1997, Pages 53-58

  Hayashibe, Hidemasa ^a   Asayama, Kohtaro ^a   Nakane, Takaya ^a   Uchida, Norihiko ^a   Kawada, Yasusuke ^a   Nakazawa, Shinpei ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

apolipoproteins; atherosclerosis; child; cholesteryl ester transfer protein; lipoproteins; obesity

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL ESTER; LIPOPROTEIN;

ADOLESCENT; ARTICLE; ATHEROGENESIS; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; OBESITY; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; APOLIPOPROTEINS; ARTERIOSCLEROSIS; BODY HEIGHT; BODY MASS INDEX; CARRIER PROTEINS; CHILD; CHOLESTEROL ESTER TRANSFER PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; MALE; OBESITY, MORBID; RISK FACTORS; TRIGLYCERIDES;

EID: 0031048686     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)06014-5     Document Type: Article

References (33)

1. Morton RE, Zilversmit DB. Purification and characterization of lipid transfer protein(s) from human lipoprotein-deficient plasma. J Lipid Res 1982;23:1058-1067.
2. Takahashi K, Jiang XC, Sakai N et al. A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins. J Clin Invest 1993;92:2060-2064.
3. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med 1977;62:707-714.
4. Marotti KR, Castle CK, Boyle TP, Lin AH, Murray RW, Melchior GW. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 1993;364:73-75.
5. Hayek T, Masucci-Magoulas L, Jiang X et al. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J Clin Invest 1995;96:2071-2074.
6. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease; a 26-year follow-up on participants in the Framingham Heart Study. Circulation 1983;67:968-977.
7. Bertiere MC, Fumeron F, Rigaud D, Apfelbaum M, Girard-Globa A. Low high density lipoprotein-2 concentrations in obese male subjects. Atherosclerosis 1988;73:57-61.
8. Kannel WB. Metabolic risk factors for coronary heart disease in woman: perspective from the Framingham Study. Am Heart J 1987;114:419-423.
9. Dullaart RP, Sluiter WJ, Dikkeschei LD, Hoogenberg K, Van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest 1994;24:188-194.
10. Arai T, Yamashita S, Hirano K et al. Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity. Arterioscler Thromb 1994;14:1129-1136.
11. Stary HC. Macrophages macrophage form cells, and eccentric intimal thickening in the coronary arteries of young children. Atherosclerosis 1987;64:91-108.
12. Asayama K, Hayashibe H, Mishiku Y, Honda M, Ito H, Nakazawa S. Increased activity of plasma cholesteryl ester transfer protein in end-stage renal disease children maintained on continuous ambulatory peritoneal dialysis. Nephron 1996;72:231-236.
13. Asayama K, Hayashibe H, Dobashi K, Uchida N, Kawada Y, Nakazawa S. Relationships between biochemical abnormalities and anthropometric indices of overweight adiposity and body fat distribution in Japanese elementary school children. Int J Obes 1995;19:253-259.
14. Brozek J, Grende J, Anderson T, Keys, A. Densitometric analysis of body composition: revision of some quantitative assumptions. Ann NY Acad Sci 1963;110:113-140.
15. Nagamine S, Suzuki S. Anthropometry and body composition of Japanese young men and women. Hum Biol 1964;36:8-15.
16. Havel RJ, Eder HA, Bragdon, JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-1353.
17. Albers JJ, Tollefson JH, Chen CH, Steinmetz A. Isolation and characterization of human plasma lipid transfer proteins. Arteriosclerosis 1984;4:49-58.
18. Yamashita S, Hui DY, Wetterau JR et al. Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency. Metabolism 1991;40:756-763.
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol without use of the preparative ultracentrifuge. Clin Chem 1972;18:499.
20. Freedmann DS, Burke GL, Harsha DW et al. Relationship of changes in obesity to serum lipid and lipoprotein changes in childhood and adolescence. JAMA 1985;254:515-520.
21. Zwiauer KF, Pakosta R, Mueller T, Widhalm K. Cardiovascular risk factors in obese children in relation to weight and body fat distribution. J Am Coll Nutr 1992;11:41S-50S.
22. Knip M, Nuutinen O. Long-term effects of weight reduction on serum lipids and plasma insulin in obese children. Am J Clin Nutr 1993;57:490-493.
23. Wattigney WA, Harsha DW, Srinivasan SR, Webber LS, Berenson GS. Increasing impact of obesity on serum lipids and lipoproteins in young adults. The Bogalusa Heart Study Arch Intern Med 1991;151:2017-2022.
24. Jiang XC, Moulin P, Quinet E et al. Mammalian adipose tissue and muscle are major sources of lipid transfer protein. J Biol Chem 1991;266:4631-4639.
25. Bagdade JD, Lane JT, Subbaiah PV, Otto ME, Ritter MC. Accelerated cholesteryl ester transfer in noninsulin-dependent diabetes mellitus. Atherosclerosis 1993;104:69-77
26. Sutherland WH, Walker RJ, Lewis-Earned NJ, Pratt H, Tillman HC. The effect of acute hyperinsulinemia on plasma cholesteryl ester transfer protein activity in patients with non-insulin-dependent diabetes mellitus and healthy subjects. Metabolism 1994;43:1362-1366.
27. Bagdade JD, Dunn FL, Eckel RH, Ritter MC. Intraperitoneal insulin therapy corrects abnormalities in cholesteryl ester transfer and lipoprotein lipase activities in insulin-dependent diabetes mellitus. Arterioscler Thromb 1994;14:1933-1939.
28. Mann CJ, Yen FT, Grant AM, Bihain BE. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest 1991;88:2059-2066.
29. Serrat-Serrat J, Ordonez-Llanos J, Serra-Grima R et al. Marathon runners presented lower serum cholesteryl ester transfer activity than sedentary subjects. Atherosclerosis 1993;101:43-49.
30. Seip RL, Moulin P, Cocke T et al. Exercise training decreases plasma cholesteryl ester transfer protein. Arterioscler Thromb 1993;13:1359-1367.
31. Quinet E, Tall A, Ramakrishnan R, Rudel L. Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. J Clin Invest 1991;87:1559-1566.
32. McPherson R, Mann CJ, Tall AR et al. Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables. Arterioscler Thromb 1991;11:797-804.
33. Masucci-Magoulas L, Plump A, Jiang XC, Walsh A, Breslow JL, Tall AR. Profound induction of hepatic cholesteryl ester transfer protein transgene expression in apolipoprotein E and low density lipoprotein receptor gene knockout mice. A novel mechanism signals changes in plasma cholesterol levels. J Clin Invest 1996;97:154-161.